<DOC>
	<DOCNO>NCT02542371</DOCNO>
	<brief_summary>The purpose study measure arterial 99mTc-Tilmanocept uptake use single photon emission compute tomography ( SPECT/CT ) scan HIV infected subject know subclinical coronary atherosclerosis assess contrast-enhanced coronary compute tomography angiography ( CCTA ) .</brief_summary>
	<brief_title>Use 99mTc Tilmanocept Imaging Arterial Inflammation</brief_title>
	<detailed_description>Detailed Description : Patients HIV show increase atherosclerotic risk compare age-matched control , risk think relate increased systemic immune activation . Specifically , systemic immune activation may contribute destabilize coronary atherosclerotic plaque , lead plaque rupture myocardial infarction . This study intend measure arterial uptake macrophage specific marker 99mTc-Tilmanocept use single photon emission compute tomography , apply initially group HIV-infected patient know subclinical coronary atherosclerosis CCTA . Moreover , traditional marker CVD risk inflammatory marker assess relation CV imaging outcome . Positive finding index HIV group know subclinical atherosclerosis prompt subsequent study three comparison group , .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Arteritis</mesh_term>
	<criteria>HIV infected subject know subclinical atherosclerosis : Inclusion criterion : men woman , age 18+ , document HIV infection current use antiretroviral therapy ( ART ) , change regimen within last 3 month history subclinical atherosclerosis CCTA Exclusion criterion : pregnancy breastfeed know active opportunistic infection require ongoing medical therapy ( include Hepatitis B/C ) CD4 count &lt; 50 cells/mm3 history angina , myocardial infarction , acute coronary syndrome , coronary artery stenting surgery recent and/or current treatment prescription , systemic steroid antiinflammatory/immune suppressant medical therapy current use statin use statin &gt; 1 month within last 6 month know allergy dextrans and/or DPTA and/or radiometals and/or iodinate contrast medium eGFR &lt; 60 ml/min/1.73 m2 calculate CDKEPI contraindication beta blocker nitroglycerin significant radiation exposure ( &gt; 2 CT angiogram ) receive within past 12 month BMI &gt; 35 kg/m2 waist circumference &gt; 70 cm ( scanner limitation ) HIV infected subject without known subclinical atherosclerosis : Inclusion criterion : men woman , age 18+ , document HIV infection current use antiretroviral therapy ( ART ) , change regimen within last 3 month history clean aorta/ coronary CCTA Exclusion criterion : Same exclusion criterion HIV infect subject know subclinical atherosclerosis HIV negative subject know subclinical atherosclerosis : Inclusion criterion : men woman , age 18+ , without document HIV infection history subclinical atherosclerosis CCTA Exclusion criterion : pregnancy breastfeed history angina , myocardial infarction , acute coronary syndrome , coronary artery stenting surgery recent and/or current treatment prescription , systemic steroid antiinflammatory/immune suppressant medical therapy current use statin use statin &gt; 1 month within last 6 month know allergy dextrans and/or DPTA and/or radiometals and/or iodinate contrast medium eGFR &lt; 60 ml/min/1.73 m2 calculate CDKEPI contraindication beta blocker nitroglycerin significant radiation exposure ( &gt; 2 CT angiogram ) receive within past 12 month BMI &gt; 35 kg/m2 waist circumference &gt; 70 cm ( scanner limitation ) HIV negative subject without known subclinical atherosclerosis : Inclusion criterion : men woman , age 18+ , without document HIV infection history clean aorta/coronaries CCTA Exclusion criterion : Same exclusion criterion HIV negative subject know subclinical atherosclerosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Tilmanocept</keyword>
</DOC>